Vendor commercial due diligence for the sale of Cognite

Deal typeM&A
IndustryLife Sciences

BDO were commissioned for the vendor commercial due diligence for the proposed sale of Cognite.

Founded in 2012 and headquartered in London, Cognite is a high quality independent healthcare strategy and medical communications agency which serves both Pharmacos and Biotech’s. Its differentiated offering is based on specialist scientific knowledge in rare diseases and occupies the valuable strategic intersect between medical and commercial strategy communications.

Cognite has experienced exceptional growth in recent years and is now entering a new growth phase, with plans to expand to the US and Asia and to increase its capabilities as a leading healthcare communication agency.

Amid high interest, Vespa Capital was selected by Cognite’s management team as their equity partner due to Vespa Capital’s track record of providing tailored solutions which assist the growth of businesses serving the biopharmaceutical market. This specialist industry understanding assisted Vespa Capital in the identification of strong medium and long-term growth opportunities available to the Cognite team.

BDO were also happy to provide top up commercial due diligence to investors to help further build out their key growth concepts. 

“The BDO team, led by Gurpal Ahluwalia, brought relevant and useful experience from their extensive work within the broader medical communications and healthcare strategy market. This market knowledge was extremely helpful both in terms of verifying the quality of the business and its management team, and in confirming the significant market opportunities available to best in class and focussed businesses in this space.”

David Forbes, Partner, Vespa Capital